Group One Trading, L.P. Entera Bio Ltd. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Entera Bio Ltd. stock. As of the latest transaction made, Group One Trading, L.P. holds 51 shares of ENTX stock, worth $90. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 51
-0.0%
Holding current value
$90
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ENTX
# of Institutions
18Shares Held
5.35MCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL3.88MShares$6.91 Million4.83% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY672KShares$1.2 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT402KShares$714,7020.11% of portfolio
-
Ubs Group Ag168KShares$298,3680.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny57.6KShares$102,5280.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $51.3M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...